Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

“A Day of Results”: Senate Passes Compounding/Track & Trace

This article was originally published in RPM Report

Executive Summary

On November 18, the Senate enacted passed H.R. 3204, the Drug Quality and Security Act by a voice vote, and the new pharmacy compounding/supply chain security bill is set to be signed into law. One of the key reasons for that was the support from Senate Health Subcommittee ranking member, Lamar Alexander, whose home state experienced a disproportionate impact from the meningitis outbreak traced back to compounded products. Here are his remarks on the Senate floor immediately after the vote.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS081069

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel